Literature DB >> 24240036

Fluoroquinolone resistant mechanisms in methicillin-resistant Staphylococcus aureus clinical isolates in Cairo, Egypt.

Rasha A Hashem1, Aymen S Yassin, Hamdallah H Zedan, Magdy A Amin.   

Abstract

INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) is a persistent problem in community and health care settings. Fluoroquinolones are among the drugs of choice used to treat MRSA infections. This study aims to identify different mechanisms of fluoroquinolne resistance in local MRSA random sampling isolates in Cairo, Egypt.
METHODOLOGY: A total of 94 clinical isolates of S. aureus were collected from two major University hospitals in Cairo. Identification was confirmed by appropriate morphological, cultural, and biochemical tests. The antibiotic susceptibility pattern was determined for all isolates. The possible involvement of efflux pumps in mediating fluoroquinolone resistance as well as changes in the quinolone resistance determining region (QRDR) of gyrA and gyrB genes were investigated
RESULTS: A total of 45 isolates were found to be MRSA, among which 26 isolates were found to be fluoroquinolone-resistant. The MIC values of the tested fluoroquinolones in the presence of the efflux pump inhibitors omeprazole and piperine were reduced. Measuring the uptake of ciprofloxacin upon the addition of the efflux pump inhibitor omeprazole, an increased level of accumulation was observed. Non-synonymous and silent mutations were detected in the QRDR of gyrA and gyrB genes.
CONCLUSIONS: These results shed light on some of the resistance patterns of MRSA strains isolated from local health care settings in Cairo, Egypt. The resistance of these MRSA towards fluoroquinolones does not depend only on mutation in target genes; other mechanisms of resistance such as the permeability effect, efflux pumps and decreased availability of quinolones at the target site can also be involved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24240036     DOI: 10.3855/jidc.3105

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  4 in total

Review 1.  Streptomyces as a Prominent Resource of Future Anti-MRSA Drugs.

Authors:  Hefa Mangzira Kemung; Loh Teng-Hern Tan; Tahir Mehmood Khan; Kok-Gan Chan; Priyia Pusparajah; Bey-Hing Goh; Learn-Han Lee
Journal:  Front Microbiol       Date:  2018-09-24       Impact factor: 5.640

2.  Association between fluoroquinolone resistance and MRSA genotype in Alexandria, Egypt.

Authors:  Mustafa Alseqely; Mae Newton-Foot; Amal Khalil; Mostafa El-Nakeeb; Andrew Whitelaw; Alaa Abouelfetouh
Journal:  Sci Rep       Date:  2021-02-19       Impact factor: 4.379

3.  Soil-Associated Bacillus Species: A Reservoir of Bioactive Compounds with Potential Therapeutic Activity against Human Pathogens.

Authors:  Galal Yahya; Asmaa Ebada; Eman M Khalaf; Basem Mansour; Nehal A Nouh; Rasha A Mosbah; Sameh Saber; Mahmoud Moustafa; Sally Negm; Mohamed M A El-Sokkary; Ahmed M El-Baz
Journal:  Microorganisms       Date:  2021-05-24

4.  The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains.

Authors:  Wioletta Adamus-Białek; Anna Baraniak; Monika Wawszczak; Stanisław Głuszek; Beata Gad; Klaudia Wróbel; Paulina Bator; Marta Majchrzak; Paweł Parniewski
Journal:  Mol Biol Rep       Date:  2018-07-14       Impact factor: 2.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.